BA

Barkha Agarwal

Active Director Director DIN 09382122
DIN 09382122 First appointment Oct 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Barkha Agarwal

Data last updated:

Barkha Agarwal is a Director at Jsbm Pharma Private Limited (since 2021). The company operates in Pharma. Jsbm Pharma Private Limited reported revenue of ₹80.7 Lakh (FY 2025).

DIN 09382122
Primary Designation Director
Industry Pharma
First Appointment 29 Oct 2021
Oldest Company Age 5 yrs
Largest company Jsbm Pharma Private Limited · ₹80.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jsbm Pharma Private Limited U24230MP2021PTC058206
Director29 Oct 20212021₹80.7 Lakh (FY 2025)Active

Board colleagues of Barkha Agarwal

Directorship timeline

Open interactive timeline →
Jsbm Pharma Private Limited
Premium access

Shareholding and investment profile for Barkha Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Barkha Agarwal

Barkha Agarwal currently holds 1 directorship: Jsbm Pharma Private Limited (Director, since 29 Oct 2021, revenue ₹80.7 Lakh (FY 2025)).

Barkha Agarwal was first appointed on 29 Oct 2021 as Director at Jsbm Pharma Private Limited.

The current boards of Barkha Agarwal's companies include Ankit Agrawal (Jsbm Pharma Private Limited), Rani Agrawal (Jsbm Pharma Private Limited), Sumit Agrawal (Jsbm Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available